<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Timothy J. Ley, Andrew Hantel et al.|New England Journal of Medicine|2016Cited by 783
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsGaspar J. Kitange, Jann N. Sarkaria, Brett L. Carlson et al.|Neuro-Oncology|2008Cited by 387
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panelJann N. Sarkaria, C. David James, Lin Yang et al.|Molecular Cancer Therapeutics|2007Cited by 203
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cellsLing Cen, Jann N. Sarkaria, Brett L. Carlson et al.|Neuro-Oncology|2012Cited by 187
Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well ToleratedRamzi Abboud, Rizwan Romee, Jesse Keller et al.|Biology of Blood and Marrow Transplantation|2016Cited by 164